Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA staff question validity of benefit seen with AstraZeneca drug
Yahoo/Reuters
Monday, June 23, 2014 - 9:42am
tags:
FDA, AstraZeneca, olaparib, ovarian cancer
AbbVie Raises Outlook on Strong Performance Amid Shire Offer
Bloomberg
Monday, June 23, 2014 - 9:41am
tags:
AbbVie, Shire, M&A, guidance
Pfizer Arthritis drug leads to full head of hair
CNBC
Monday, June 23, 2014 - 9:40am
tags:
Pfizer, alopecia, rheumatoid arthritis, Xeljanz
AbbVie’s Gonzalez Seeks Quick Diversity With Shire Offer
Bloomberg
Monday, June 23, 2014 - 9:39am
tags:
AbbVie, Richard Gonzalez, Shire, M&A, diversification
Shire to set out AstraZeneca-style defense against AbbVie
Yahoo/Reuters
Monday, June 23, 2014 - 9:37am
tags:
Shire, Pfizer, M&A, AstraZeneca, AbbVie
Johnson & Johnson: Expect Dividend Growth To Accelerate In Next 2 Years
Seeking Alpha
Sunday, June 22, 2014 - 9:22am
tags:
JNJ
Verastem Inc.'s Upcoming Catalysts
Motley Fool
Sunday, June 22, 2014 - 9:20am
tags:
Verastem
What Big Pharma Could Learn From A Craft Beer Brewer
Forbes
Saturday, June 21, 2014 - 11:58am
tags:
Who Will Win This $45 Billion Market?
Motley Fool
Saturday, June 21, 2014 - 11:45am
tags:
Sanofi, Novo Nordisk, diabetes, type 1 diabetes, type 2 diabetes
Can This Growth Driver Push AstraZeneca Forward? (video)
Motley Fool
Saturday, June 21, 2014 - 11:43am
tags:
AstraZeneca
Shire Rejecting AbbVie’s Bid Puts It in Play: Real M&A
Bloomberg
Saturday, June 21, 2014 - 11:41am
tags:
Shire, AbbVie, M&A
AbbVie’s Shire Push Won’t Face Pfizer Hurdles in Takeover
Bloomberg
Saturday, June 21, 2014 - 11:39am
tags:
AbbVie, Shire, M&A
Is Gilead Sciences, Inc. Destined for Greatness?
Motley Fool
Saturday, June 21, 2014 - 11:36am
tags:
Gilead Sciences
AstraZeneca's Naloxegol Data Published
Yahoo/Zacks
Saturday, June 21, 2014 - 11:33am
tags:
AstraZeneca, Naloxegol, opioid-induced constipation
Belviq Sales Flat - Is Seasonality Coming Into Play? (ARNA)
Seeking Alpha
Saturday, June 21, 2014 - 11:31am
tags:
Belviq, weight loss, obesity, Arena Pharmaceuticals
Dear Sen. Waxman, Leave Gilead Alone
Barron's
Saturday, June 21, 2014 - 11:29am
tags:
Gilead Sciences, Sovaldi
FDA approves Cubist drug to treat acute skin infections
Yahoo/Reuters
Friday, June 20, 2014 - 8:05pm
tags:
FDA, Cubist Pharmaceuticals, antibiotics, Sivextro
Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does
Seeking Alpha
Friday, June 20, 2014 - 6:20pm
tags:
Allergan, Perrigo Company, taxes, Valeant Pharmaceuticals, M&A
AbbVie’s Shire Push Won’t Face Pfizer Hurdles in Takeover
Bloomberg
Friday, June 20, 2014 - 6:19pm
tags:
Shire, AbbVie, M&A, Pfizer
AbbVie: Is Shire Just Playing Hard to Get?
Barron's
Friday, June 20, 2014 - 6:18pm
tags:
AbbVie, Shire, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.